Cargando…

Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD

BACKGROUND: Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnasamy, Rathika, Tan, Sven-Jean, Hawley, Carmel M., Johnson, David W., Stanton, Tony, Lee, Kevin, Mudge, David W., Campbell, Scott, Elder, Grahame J., Toussaint, Nigel D., Isbel, Nicole M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584006/ https://www.ncbi.nlm.nih.gov/pubmed/28870151 http://dx.doi.org/10.1186/s12882-017-0705-4

Ejemplares similares

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
por: Lioufas, Nicole, et al.
Publicado: (2019)

Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease
por: Krishnasamy, Rathika, et al.
Publicado: (2015)

Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease
por: Krishnasamy, Rathika, et al.
Publicado: (2015)

Vitamin K in CKD: A Game-Changer or By-Stander
por: Krishnasamy, Rathika, et al.
Publicado: (2023)

Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD
por: Stanley, Isabelle Kitty, et al.
Publicado: (2022)

Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3–4 CKD—results from a placebo-controlled randomized trial
por: Tiong, Mark K, et al.
Publicado: (2022)

A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients
por: Campbell, Katrina L, et al.
Publicado: (2014)

Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study
por: Kaisar, Mohd O, et al.
Publicado: (2009)

The impact of automated eGFR reporting and education on nephrology service referrals
por: Noble, Euan, et al.
Publicado: (2008)

A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients – the HEALTHY-CATH trial
por: Broom, Jennifer K, et al.
Publicado: (2012)

Telemedicine for Outpatient Care of Kidney Transplant and CKD Patients
por: Lambooy, Sebastiaan, et al.
Publicado: (2021)

Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
por: Mudge, David W, et al.
Publicado: (2011)

The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial
por: McMahon, Emma J, et al.
Publicado: (2012)

Physical activity for people with chronic kidney disease: an international survey of nephrologist practice patterns and research priorities
por: Taryana, Airis Astiani, et al.
Publicado: (2019)

Life-threatening adenovirus infection in a kidney transplant recipient
por: Barraclough, Katherine, et al.
Publicado: (2009)

Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
por: Davis, Emma, et al.
Publicado: (2016)

The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)—A Systematic Review
por: Pimentel, Ana, et al.
Publicado: (2021)

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
por: Mudge, David W, et al.
Publicado: (2009)

A Systematic Review of Scope and Consistency of Outcome Measures for Physical Fitness in Chronic Kidney Disease Trials
por: Jegatheesan, Dev K., et al.
Publicado: (2021)

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
por: Barraclough, Katherine A, et al.
Publicado: (2009)

Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study
por: Wilson, Gregory J., et al.
Publicado: (2019)

Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: An interventional cohort study
por: van Eps, Carolyn L, et al.
Publicado: (2011)

Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial
por: McFarlane, Catherine, et al.
Publicado: (2021)

Probable tacrolimus toxicity from tibolone co-administration in a woman: a case report
por: Clark, Carolyn J, et al.
Publicado: (2010)

Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients
por: Broom, Jennifer K, et al.
Publicado: (2009)

Changes in Markers of Mineral Metabolism After Living Kidney Donation
por: Tan, Sven-Jean, et al.
Publicado: (2017)

Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study
por: Zhan, Zhipeng, et al.
Publicado: (2019)

Where is the link between mineral bone markers and cardiovascular disease in CKD?
por: Cozzolino, Mario, et al.
Publicado: (2015)

Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review
por: Lioufas, Nicole, et al.
Publicado: (2019)

Phosphate Balance and CKD–Mineral Bone Disease
por: Sprague, Stuart M., et al.
Publicado: (2021)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy
por: Gately, Ryan, et al.
Publicado: (2022)

Infectious Complications Following Kidney Transplantation—A Focus on Hepatitis C Infection, Cytomegalovirus Infection and Novel Developments in the Gut Microbiota
por: Chan, Samuel, et al.
Publicado: (2019)

Echocardiographic predictors of all-cause mortality in patients with left ventricular ejection fraction >35%: Value of guideline based assessment of diastolic dysfunction
por: Prasad, Sandhir B., et al.
Publicado: (2019)

Racial Variations in the Markers of Mineral Bone Disorders in CKD Patients in South Africa
por: Waziri, Bala, et al.
Publicado: (2017)

Editorial: Mineral and Bone Disorder in CKD
por: Printza, Nikoleta, et al.
Publicado: (2022)

Temporal Changes in Deceased Kidney Donor Characteristics in Australia
por: Chan, Samuel, et al.
Publicado: (2016)

PREBIOTIC: a study protocol of a randomised controlled trial to assess prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset — a feasibility study
por: Chan, Samuel, et al.
Publicado: (2023)

Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation
por: Chan, Samuel, et al.
Publicado: (2020)

Improving Bone Mineral Density Screening by Using Digital X‐Radiogrammetry Combined With Mammography
por: Rao, Amshuman, et al.
Publicado: (2022)

Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
por: Dheda, Shyam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k62pl8ppb5nprn0amo79765oi8